Urinary incontinence: modern standards of treatment and new prospects


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

全文:

受限制的访问

作者简介

G. Kasyan

Email: g.kasyan@gmail.com

参考

  1. Abrams P., Andersson K.E., Birder L. et al. Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn. 2010; 29: 213-240.
  2. Shamliyan T.A., Kane R.L., Wyman J. et al. Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann Intern Med. 2008; 148: 459-473.
  3. Dumoulin C., Hay-Smith J. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev. 2010: CD005654.
  4. Richter H.E., Burgio K.L., Brubaker L. et al. Continence pessary compared with behavioral therapy or combined therapy for stress incontinence: a randomized controlled trial. Obstet Gynecol. 2010; 115: 609-617.
  5. Cody J.D., Richardson K., Moehrer B. et al. Oestrogen therapy for urinary incontinence in postmenopausal women. Cochrane Database Syst Rev 2009 Oct 7; (4): CD001405Hong J.H., Choo M.S., Lee K.S. Long-term results of laparoscopic Burch colposuspension for stress urinary incontinence in women. J Korean Med Sci. 2009; 24(6): 1182-1186.
  6. Lucas M.G., Betredinova D., et al. EAU guidelines on surgical treatment of urinary incontinence. Eur Urol 2013.
  7. Pushkar D., Kasyan G., Gvozdev M. et al. Analysis of 1000 cases of synthetic midurethral slings used for treatment of female urinary incontinence - a single-center experience. Central Euaropean Journal of Urology. 2011; 64(4): 243.
  8. Lucas M.G., Bosch R.J., Burkhard F.C. et al. EAU guidelines on surgical treatment of urinary incontinence. Eur. Urol. 2012; 62(6): 1118—1129.
  9. Dmochowski R.R., Blaivas J.M., Gormley E.A., et al. Female Stress Urinary Incontinence Update Panel of the American Urological Association Education and Research, Whetter LE. Update of AUA guideline on the surgical management of female stress urinary incontinence. J Urol 2010; 183(5): 1906—1914.
  10. Abdel-Fattah M., Ford J.A., Lim C.P., et al. Single-incision mini-slings versus standard midurethral slings in surgical management of female stress urinary incontinence: a meta-analysis of effectiveness and complications. Eur Urol. 2011; 60(3): 468—480.
  11. Kirchin V., Page T., Keegan P.E. et al. Urethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev 2012; (2): CD003881.
  12. Chapple C.R., Khullar V., Gabriel Z. et al. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur Urol 2008; 54(3): 543—562.
  13. McDonagh M.S., Selover D., Santa J. et al. Drug class review: agents for overactive bladder. Final report. Update 4. Portland, Oregon: Oregon Health & Science University, March 2009.
  14. Abrams P., Swift S. Solifenacin is effective for the treatment of OAB dry patients: a pooled analysis. Eur Urol. 2005; 48(3): 483—487.
  15. Chapple C.R., Martinez-Garcia R., Selvaggi L. et al. A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial. Eur Urol. 2005; 48(3): 464—470.
  16. Cardozo L., Heßdörfer E., Milani R. et al. Solifenacin in the treatment of urgency and other symptoms of overactive bladder: results from a randomized, double-blind, placebo-controlled, rising-dose trial. Br J Urol Int. 2008; 102(9).
  17. Herschorn S., Bruschini H., Comiter C. et al. Surgical treatment of stress incontinence in men. Neurourol Urodyn. 2010; 29: 179—190.
  18. Porena M., Mearini E., Mearini L. et al. Voiding dysfunction after radical retropubic prostatectomy: more than external urethral sphincter deficiency. Eur Urol. 2007; 52: 38—45.
  19. Thuroff J.W., Abrams P., Andersson K.E. et al. EAU guidelines on urinary incontinence. Eur Urol. 2011; 59: 387—400.
  20. Azzouzi A.R., Ballereau C., Desgranchamps F. et al. Management of male urinary incontinence after radical prostatectomy: incidence and role of urodynamic assessment and electromyography. Prog Urol. 2008; 18: 14—18.
  21. Porena M., Mearini E., Mearini L. et al. Voiding dysfunction after radical retropubic prostatectomy: more than external urethral sphincter deficiency. Eur Urol. 2007; 52: 38—45.
  22. Bauer R.M., Gozzi C., Hubner W. et al. Contemporary management of postprostatectomy incontinence. Eur Urol. 2011; 59: 985—996.
  23. Ficarra V., Novara G., Artibani W. et al. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur Urol.2009; 55: 1037— 1063.
  24. Bauer R.M., Bastian P.J., Gozzi C. et al. Postprostatectomy incontinence: all about diagnosis and management. Eur Urol. 2009; 55: 322—333.
  25. Welk B.K., Herschorn S. Are male slings for post-prostatectomy incontinence a valid option? Curr Opin Urol. 2010; 20: 465—470.
  26. Welk B.K., Herschorn S. The male sling for post-prostatectomy urinary incontinence: a review of contemporary sling designs and outcomes. BJU Int. 2012; 109: 328—344.
  27. Van der Aa F., Drake M.J., Kasyan G.R., et al. for the Young Academic Urologist Functional Urology Group. The Artifical Urinary Sphincter after a quarter of a Century: A critical systematic review of its use in male non-neurogenic incontinence. Eur Urol. 2012; 63: 681—689.
  28. Bauer R.M., Bastian P.J., Gozzi C., et al. Postprostatectomy incontinence: all about diagnosis and management. Eur Urol. 2009; 55: 322—333.
  29. Athanasopoulos A., Chapple C., Fowler C., et al. The role of antimuscarinics in the management of men with symptoms of overactive bladder associated with concomitant bladder outlet obstruction: an update. Eur Urol. 2011; 60: 94—105.
  30. Lee J.Y., Kim H.W., Lee S.J. et al. Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder. BJU Int. 2004; 94: 817—820.
  31. Van Kerrebroeck P., Haab F., Angulo J.C. et al. Efficacy and safety of solifenacin plus tamsulosin OCAS in men with voiding and storage lower urinary tract symptoms: results from a phase 2, dose-finding study (SATURN). Eur Urol. 2013; 64(3): 398—407.
  32. Kaplan S.A., Roehrborn C.G., Rovner E.S. et al. Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial. JAMA.2006; 296: 2319—2328.
  33. Chapple C., Herschorn S., Abrams P. et al. Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers. Eur Urol. 2009; 56: 534—541.
  34. Fujihara A., Ukimura O., Iwata T. The efficacy of mirabegron as the second line therapy of oab after the first line therapy using antimuscarinic agent. ICS Annual Meeting, Beijing 2012, Abs. 346.
  35. Nitti V., Herschorn S., Khullar V. Efficacy of mirabegron in patients with overactive bladder (OAB): prespecified analysis of three randomised, double-blind, placebocontrolled, phase iii studies. ICS Annual Meeting, Beijing 2012, Abs. 222.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2013
##common.cookie##